Insider & Institutional Ownership
60.2% of Smead Value C shares are owned by institutional investors. Comparatively, 13.4% of iCoreConnect shares are owned by institutional investors. 10.3% of Smead Value C shares are owned by insiders. Comparatively, 59.4% of iCoreConnect shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares Smead Value C and iCoreConnect”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Smead Value C | N/A | N/A | -$6.48 million | N/A | N/A |
| iCoreConnect | $11.05 million | 0.00 | -$15.55 million | ($44.40) | 0.00 |
Profitability
This table compares Smead Value C and iCoreConnect’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Smead Value C | N/A | N/A | -17.75% |
| iCoreConnect | -263.12% | -1,451.73% | -171.32% |
Volatility and Risk
Smead Value C has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, iCoreConnect has a beta of 33.29, indicating that its share price is 3,229% more volatile than the S&P 500.
Summary
Smead Value C beats iCoreConnect on 5 of the 8 factors compared between the two stocks.
About Smead Value C
SVF Investment Corp. 3 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was formerly known as SVF Investment III Corp. and changed its name to SVF Investment Corp. 3 in January 2021. SVF Investment Corp. 3 was incorporated in 2020 and is based in San Carlos, California.
About iCoreConnect
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.
Receive News & Ratings for Smead Value C Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smead Value C and related companies with MarketBeat.com's FREE daily email newsletter.
